Hyperrab 2 mL Rabies Immune Globulin (Human)
Count Per Box or Pack
Boxes/Packs Per Carton
Grifols is a global company that since 1909 has enhanced the health and well-being of people around the world. Our four divisions - Bioscience, Diagnostic, Hospital, and Bio Supplies - develop, produce, and market innovative solutions and services in more than 100 countries.
Grifols' origin lies in the laboratory founded in 1940 in Barcelona by Dr Josep A. Grífols Roig, a hematologist and scientist (although its origin dates back to the Instituto Central de Análisis Clínicos, a company founded in 1909 by Josep Antonio Grífols Roig, which will be a pioneer in Spain in clinical analysis and in the introduction of blood conservation and transfusion techniques). His son, Dr Josep A. Grifols Lucas was the first researcher to publish the plasmapheresis procedure in 1952. The company introduced its liquid IVIG product into the European market in the mid-1990s.
Probitas Pharma, S.A. was incorporated with high limited liability under Spanish law on 22 June 1987; on 27 June 2005 the company changed its name to Grifols, S.A. In 2003 the company acquired certain assets of the Los Angeles-based Alpha Therapeutic (US subsidiary of Mitsubishi Pharma) as the basis of its American expansion. On May 17, 2006, Grifols securities were listed on Spain's Mercado Continuo.
In 2009, CSL Limited attempted to takeover Talecris Biotherapeutics (the former plasma business of Bayer HealthCare LLC, Biological Products Division) for $3,1 billion but was stopped by the Federal Trade Commission. On June 1, 2011, a year after announcing the $4 billion deal, Grifols completed a takeover of Talecris Biotherapeutics, headquartered in Research Triangle Park in North Carolina, with over 2000 employees.
Grifols acquired the blood transfusion diagnostics unit from Novartis in 2013 as a "platform for global expansion". This unit is based in Emeryville, California and was a part of Chiron acquired by Novartis in 2006.
In 2015, the company acquired a 45% stake in Alkahest as part of planned co-development of "plasma-based products for the treatment of cognitive decline in aging and disorders of the CNS, including Alzheimer's."In 2020 Grifols acquired the remaining stock of Alkahest “bringing its ownership of Alkahest to 100%”.
In December 2016, Grifols acquired Hologics interest in their existing joint blood screening unit for $1.85 billion.
Product Website Reference:
About Luen Cheong Hong
Luen Cheong Hong (LCH) Ltd is one of the leading healthcare companies as pharmaceuticals distributor, medical supplies & medical equipment wholesale supplier in Hong Kong and Macau with over 80 years of experience, supplying name-brand drugs, generic drugs, injectables, OTC (over the counter) healthcare products, medical device equipment, medical consumables, and health-care products. LCH is the trusted partner of leading international healthcare, pharmaceutical companies, and medical device equipment companies.
LCH was founded in Shanghai in the 1940s, and incorporated as a limited company in Hong Kong in 1952, being one of the oldest pharmaceutical distributors and medical supplier in Asia Pacific with active operations. LCH currently represent a number of leading international pharmaceutical companies and medical supplies companies to distribute medical products. Our distribution partners include Australia's Alphapharm Pty Ltd (acquired by Mylan and Viatris), Seqirus (CSL), Arrow Pharmaceuticals, N Medical, South Africa's Aspen Pharmacare, USA's Ecolab, Grifols Therapeutics, United Kingdom's Wockhardt, Mirius Coventry, France's Anios Laboratoires, Japan's Otsuka Pharmaceuticals, China's Zhende, Intco, and many more.
Today, LCH is one of the key suppliers for medical products in Hong Kong and Macau, supplying hundreds of types of medical consumable products, pharmaceuticals, and injectables. LCH distributes to all of the major public and private hospitals, Department of Health e.g. vaccination centers, fire department (COVID-19 response center), doctors, pharmacies, clinics, NGOs, five-star hotel chains, and restaurants. By owning and managing one of the largest medically compliant distribution centers and logistics system in the region, we have managed to create a seamless sales and after sales experience for our customers.
Over the years, LCH helped a number of the largest international pharmaceuticals and medical product companies from USA, United Kingdon, Europe, Japan, Australia, and China to establish their brand presence, sales, and distribution in the Asia Pacific region. LCH assisted their partners to manage the logistics and distribution of their products, marketing, local legal registration, participate in private and public tender bidding, direct sales, and establish their brand recognition.
LCH provides their partners with a set of comprehensive services in the areas of sales, marketing, and distribution solutions in Hong Kong and Macau. Such includes:
Pharmaceutical and medical products license registration to comply with local regulations
Sales of pharmaceuticals, medical devices, and healthcare products
Marketing to local users such as public / private hospitals, doctors, department of health, and pharmacies
Participation in tender business with various government entities and NGOs
Logistics management with our self-owned multi-storey warehouses, delivery team, and proprietary logistics management systems (including 3PL, 4PL)
Conform with pharmacovigilance
Wholesale Dealer License accredited by Hong Kong Drug Office and Macau Drug Office (Licensed Wholesale Dealer)
License for Secondary Re-packaging of Pharmaceuticals accredited by Hong Kong Drug Office (Licensed Pharmaceutical Manufacturer (Secondary Packaging) )
Special storage for controlled dangerous drugs
Cold Chain Storage Facilities for cold chain pharmaceutical products
Import un-registered pharmaceutical products on named patient/un-registered basis
LCH current product range covers a few core areas:
Medical devices e.g. surgical equipment, syringes
Hospital cleaning supplies
Wound treatment supplies
聯昌行在上海成立於1940年，在香港於1952年正式註冊成為有限公司，從此在香港及澳門兩地供應高質素的醫療用品。聯昌行現在獨家代理多家國際藥廠、醫療用品公司的醫療產品。合作夥伴包括澳洲的 Alphapharm Pty Ltd（被 Mylan 和 Viatris 收購）、Seqirus (CSL)、Arrow Pharmaceuticals、N Medical、南非的 Aspen Pharmacare、美國的 Ecolab、Grifols Therapeutics、英國的 Wockhardt、Mirius Coventry、法國的 Anios Laboratoires、日本的大塚製藥、中國的振德、Intco等。
時至今天，聯昌行是香港和澳門的主要醫療供應商之一。為所有公立醫院、私人醫院、衛生處 (疫苗接種中心)、消防局 (新冠防疫感染應變協調中心)、醫生、藥房、醫療用品公司、非政府機構、五星級連鎖酒店和餐廳提供數百種不同的藥物、注射劑和醫療用品物資。在香港和澳門置有其中一個最大規模的多層合規醫療倉庫和物流團隊，為客人提供最全面和最佳的銷售及售後服務體驗。
通過我司自置的多層倉庫存貨、管理物流、和送貨 （包括 3PL，4PL）
Hong Kong Medical License Reference:
Macau Medical License Reference:
The information on this website is intended for health care professionals only. Product information is for educational purposes only, and not all products or indications are licensed in every country. Product availability are subject to individual country license, rules, and regulations. The information on this website may not be reflecting the most updated information. Please contact directly for the most updated product information and availability.